Brown Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.2M | Sell |
|
|||||
|
2025
Q2 | $7.02M | Sell |
|
|||||
|
2025
Q1 | $23.7M | Sell |
|
|||||
|
2024
Q4 | $29.6M | Sell |
|
|||||
|
2024
Q3 | $100M | Sell |
|
|||||
|
2024
Q2 | $101M | Sell |
|
|||||
|
2024
Q1 | $158M | Buy |
|
|||||
|
2023
Q4 | $139M | Sell |
|
|||||
|
2023
Q3 | $118M | Sell |
|
|||||
|
2023
Q2 | $146M | Sell |
|
|||||
|
2023
Q1 | $146M | Buy |
|
|||||
|
2022
Q4 | $156M | Buy |
|
|||||
|
2022
Q3 | $77M | Buy |
|
|||||
|
2022
Q2 | $5.97M | Buy |
|
|||||
|
2022
Q1 | $7.08M | Buy |
|
|||||
|
2021
Q4 | $6.08M | Sell |
|
|||||
|
2021
Q3 | $8.5M | Sell |
|
|||||
|
2021
Q2 | $9.86M | Buy |
|
|||||
|
2021
Q1 | $9.6M | Buy |
|
|||||
|
2020
Q4 | $7.79M | Buy |
|
|||||
|
2020
Q3 | $1.06M | Buy |
|
|||||
|
2020
Q2 | $1.05M | Buy |
|
|||||
|
2020
Q1 | $647K | Buy |
|
|||||
|
2019
Q4 | $738K | Sell |
|
|||||
|
2019
Q3 | $594K | Sell |
|
|||||
|
2019
Q2 | $739K | Buy |
|
|||||
|
2019
Q1 | $747K | Hold |
|
|||||
|
2018
Q4 | $592K | Buy |
|
|||||
|
2018
Q3 | $279K | Hold |
|
|||||
|
2018
Q2 | $277K | Hold |
|
|||||
|
2018
Q1 | $255K | Sell |
|
|||||
|
2017
Q4 | $273K | Buy |
|
|||||
|
2017
Q3 | $252K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $121K | Hold |
|
|||||
|
2013
Q4 | $111K | Buy |
|